From Witty To Walmsley – The Priorities For GSK's New CEO

It's Emma Walmsley's first week at the helm of GlaxoSmithKline. What can we expect in terms of her priorities?

Emma Walmsley GSK
GSK CEO Emma Walmsley

When Emma Walmsley was revealed as the successor to Sir Andrew Witty as CEO of GlaxoSmithKline PLC, it was clear the board had opted to secure Witty's volume-first growth strategy for the company that was launched in 2015.

But the world looks quite different in 2017 than it did in 2015. What does this mean for Walmsley and...

More from Business

More from Scrip